WuXi Biologics | Briefing, News, Analysis, Research, Data

WuXi Biologics

WuXi Biologics WuXi AppTec is expected to provide world-class integrated biopharmace

WuXi Biologics is a subsidiary of the WuXi AppTec Group with branches in Wuxi, Shanghai and Suzhou. As a platform for innovative companies to realize their dream of developing new drugs, WuXi AppTec is expected to provide world-class integrated biopharmaceutical R&D and manufacturing services to more innovative biotech companies at home and abroad in the future, accelerating the process of bringing innovative biopharmaceuticals to market in China for the benefit of patients.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Feb 27, 2014

HQ location

Shanghai, China

Legal name

Wuxi Biologics (Shanghai) Co., Ltd.

Website

http://www.wuxibiologics.com.cn

info@wuxibiologics.com

Employees

501-1000

All
News
Analysis
Research

Briefing Jun 21, 2022 05:50 PM · Technology | Healthcare | Financials

Sanlian board Shenma power: the company's gross profit margin declined to a certain extent in the first quarter

Briefing Apr 19, 2022 01:35 PM · Technology | Healthcare | Industrials

Tesla unveiled a new giant 360mwh Megapack energy storage project

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Mar 13, 2022 08:49 PM · Financials

Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan

Briefing Feb 16, 2022 07:49 AM · Technology | Consumer Staples | Consumer Discretionary

The Russian court of appeal approved a fine of $26.4 million for meta

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Financials, Technology

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Feb 14, 2022 05:40 PM · Technology | Healthcare | Industrials

Blue lithium core: the application for non-public offering of shares was approved

Briefing Feb 10, 2022 06:00 PM · Technology | Healthcare

Boten increased cdmo capacity construction of API

Briefing Feb 08, 2022 03:30 PM · Healthcare

Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted

Briefing Feb 08, 2022 12:59 PM · Technology | Consumer Discretionary | Healthcare

Vosges shares: the price of products in overseas markets will increase by 3-5% in 2021, and there is still a price increase plan this year

Healthcare

Reforgene Completes Pre-B Round Financing of CNY Hundreds of Millions

EqualOcean learned that Reforgene Medicine (瑞风生物) recently announced the completion of Pre-B round financing of CNY hundreds of millions.

May 04, 2023 02:05 PM

Healthcare

Joe Future Food Completes A+ Round Financing of CNY Tens of Million

Cell-Cultured Meat Leader, Joe Future Food (周子未来), completes A+ round financing of CNY tens of million.

Apr 28, 2023 05:13 PM

Briefing Feb 08, 2022 10:59 AM · Technology | Consumer Staples | Healthcare

Yaoming biological suspended trading in Hong Kong

Briefing Feb 08, 2022 10:19 AM · Technology | Healthcare | Industrials

Esten: the rumor that "Xinsong robot will be acquired" is not true without direct cooperation with the Winter Olympic Games

Briefing Feb 08, 2022 10:09 AM · Consumer Staples | Communication | Healthcare

Agricultural driverless enterprise "Zhongke motive power" won tens of millions of yuan of a + round financing

Healthcare

Tripod, the New CRO, Completes C Round Financing of RMB Hundreds of Mn

Tripod Preclinical Research Laboratories Co., Ltd. (鼎泰集团) announced the completion of C round financing of RMB hundreds of million.

Apr 28, 2023 12:07 PM

Technology, Consumer Staples, Healthcare

HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D

Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.

Apr 23, 2023 12:20 PM

Briefing Feb 07, 2022 08:09 AM · Healthcare

The battery plant jointly built by SK innovation and Ford was started in December last year

Briefing Dec 16, 2021 09:39 AM · Consumer Staples | Healthcare | Financials

Financial Associated Press, December 16 - Hong Kong biomedical stocks rebounded, with Wuxi apptec up more than 8% and Yaoming biology up more than 5%.

Briefing Dec 15, 2021 02:49 PM · Healthcare | Automotive

Wuxi apptec diving limit in the afternoon

Briefing Dec 07, 2021 10:19 AM · Financials | Technology | Consumer Staples

Radio and television express: a variety of products and applications have been certified by financial Xinchuang ecological laboratory

EqualOcean Analysis